Key result
Catheter ablation of ventricular arrhythmias in patients with 3rd generation LVADs is feasible and safe, achieving acute procedural success in all 9 patients and freedom from recurrence in 4 patients.
Why the study?
Data on catheter ablation of ventricular arrhythmias in patients with LVADs are scarce, and existing evidence predominantly consists of case reports with outdated LVADs.
Does catheter ablation reduce ventricular arrhythmia recurrence in patients with 3rd generation LVADs?
Observational (n=9)
No
Does catheter ablation reduce ventricular arrhythmia recurrence in patients with 3rd generation LVADs?
Answers are grounded in this paper and cite their sources.
Catheter ablation of ventricular arrhythmias in patients with 3rd generation LVADs is feasible, safe, and effectively reduces arrhythmia burden, with most substrates unrelated to the LVAD cannulation site.
Introduction Data on catheter ablation of ventricular arrhythmias (VA) are scarce in patients with left ventricular assist devices (LVADs) and current evidence predominantly consists of case reports with outdated LVAD. This prospective observational study reports our experience in terms of catheter ablation of VAs in patients with novel 3 rd generation LVADs. Methods and results Between 2018 and 2020, nine consecutive patients undergoing a total number of ten ablation procedures for VAs were analyzed. The mean duration between LVAD implantation and catheter ablation was 23 ± 16 months. Acute procedural success was achieved in all patients. VA substrates were not related to the LVAD scarring (cannula) site in the majority of patients. All procedures were conducted without any relevant procedure-related complications. In terms of follow-up, only one patient presented with a repeat episode of electrical storm requiring ICD-shocks 16 months after the initial ablation procedure. Four patients suffered of singular VA effectively treated with antitachycardia pacing via their ICD. The remainder were free of any VA relapse ( n = 4). Two non-procedure-related deaths occurred during follow-up. Conclusions Catheter ablation of VAs in patients with 3rd generation LVAD is feasible and leads to satisfying clinical results in terms of freedom from VA recurrence and quality of life. The majority of arrhythmia substrates in these patients are not directly related to the LVAD cannulation site and may represent a progress of heart failure. Graphic abstract
No takes yet. Share an insight, caveat, or question.
Bergau et al. (2021) conducted an observational in Ventricular arrhythmias in patients with 3rd generation LVADs (n=9). Catheter ablation was evaluated on Acute procedural success. Catheter ablation of ventricular arrhythmias in patients with 3rd generation LVADs is feasible and safe, achieving acute procedural success in all 9 patients and freedom from recurrence in 4 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: